Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Isotechnika Pharma Inc IPHAF

GREY:IPHAF - Post Discussion

Isotechnika Pharma Inc > WHAT A COINCIDENCE>>VINO MAN????
View:
Post by ISAloser247 on Nov 06, 2012 10:02am

WHAT A COINCIDENCE>>VINO MAN????

.......and to add credence to the reputation of the mutton-misleader>>>>>per chance,  on the fact of ' promising news' , +390,000   shares ARE DUMPED AT 9:30 AM,  before the bell has had a chance to stop ringing!  SOMEONE--SOMEWHERE  sure is clairvoyant!!!!!!!    BID AND ASK ,  GOOD DOCTOR,    BID AND ASK!!
Comment by penguinwins on Nov 06, 2012 10:07am
I did say promising not amazing...... Some news any news at all is promising when we still have not heard anything about the arbitration. The one thing I like about this news and program is that it costs us nothing with a chance be it slim for an upside. I also like that it is another organization running the testing so it is unbiased news.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities